North America Real-Time Polymerase Chain Reaction (qPCR) and Digital Polymerase Chain Reaction (dPCR) Devices Market, By Technology (Quantitative PCR, Digital PCR), Product Type (Reagents, Consumables, Instruments, Software), Application (Clinical Applications, Research Applications, Forensic Applications, Others), End-User (Hospitals, Diagnostic Centers, Ambulatory Centres, Home Healthcare, Clinics, Community Healthcare) - Industry Trends and Forecast to 2030.
North America Real-time Polymerase Chain Reaction (qPCR) and Digital Polymerase Chain Reaction (dPCR) Devices Market Analysis and Size
The presence of infectious diseases and genetic disorders is one of the major factors expected to boost the growth of the market in the forecast period. In addition, the rise in the attention on R&D investments by pharmaceutical companies and the technological developments in PCR technologies are further expected to cushion the market growth. However, the increasing cost of these devices is expected to impede market growth.
Data Bridge Market Research analyses that the real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market which was USD 7.70 billion in 2022, is expected to USD 16.36 billion by 2030 and is expected to undergo a CAGR of 11.8% during the forecast period. This indicates that the market value. "Quantitative PCR” segment is expected to dominate the technology segment of the market owing to the surge in government funding and greater affordability of the instruments. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Real-time Polymerase Chain Reaction (qPCR) and Digital Polymerase Chain Reaction (dPCR) Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Technology (Quantitative PCR, Digital PCR), Product Type (Reagents, Consumables, Instruments, Software), Application (Clinical Applications, Research Applications, Forensic Applications, Others), End-User (Hospitals, Diagnostic Centers, Ambulatory Centres, Home Healthcare, Clinics, Community Healthcare)
|
|
Countries Covered
|
U.S., Canada and Mexico
|
|
Market Players Covered
|
BioFire Diagnostics (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Cepheid (India), Analytik Jena AG (Germany), Meridian Bioscience, Inc. (U.S.), Promega Corporation (U.S.), BD (U.S.), and Merck KGaA (Germany) among others
|
|
Market Opportunities
|
|
Market Definition
Polymerase Chain Reaction (PCR) is a laboratory technique performed commonly to amplify DNA, thereby producing many copies of a particular section of DNA in interest. PCR is essentially used in medical and biological research for various applications such as processing DNA for sequencing, detecting the presence or absence of a gene during infection, and generating forensic DNA profiles from tiny samples of DNA.
North America Real-time Polymerase Chain Reaction (qPCR) and Digital Polymerase Chain Reaction (dPCR) Devices Market Dynamics
Drivers
- Government Initiatives for Raising Funds
There are growing government initiatives for raising funds to develop various pcr related projects to develop advanced therapeutics to treat multiple chronic and rare diseases. This is expected to increase the demand for qPCR and dPCR devices boosting market growth.
- Technological Developments in PCR Technologies
Technological developments in PCR technologies, specifically qPCR and dPCR devices, are serving as significant drivers in the market. These advancements have revolutionized molecular diagnostics by providing faster, more sensitive, and more accurate results for various applications, including infectious disease, genetic testing, and oncology research. The increased adoption of qPCR and dPCR devices has enabled researchers and clinicians to perform high-throughput analysis with improved precision, leading to better patient outcomes, streamlined workflows, and expanded research capabilities in the market.
Opportunity
- Increase in the Number of R&D Activities
The increase in R&D activities in the market presents a significant opportunity. The growing investment in R&D is driving innovation, leading to the development of advanced technologies, improved assays, and novel applications for qPCR and dPCR devices. This surge in research activities is expanding the capabilities and potential applications of these molecular diagnostic tools, opening doors for new discoveries and advancements in fields such as genomics, personalized medicine, and infectious disease diagnostics. As a result, the market can benefit from the emergence of groundbreaking solutions and the continuous evolution of PCR technologies.
Restraint/Challenge
- Acceptance and Application of MIQE Guidelines
The acceptance and application of the minimum information for publication of quantitative real-time PCR experiments (MIQE) guidelines in the market pose a challenge. While the MIQE guidelines provide a framework for standardizing qPCR and dPCR experiments, ensuring data accuracy and reproducibility, their widespread implementation is not yet fully realized. The adoption of MIQE guidelines requires a shift in laboratory practices, data reporting, and researcher awareness, which can be met with resistance and logistical challenges. Overcoming these barriers and achieving widespread acceptance of MIQE guidelines remains a challenge in the market, hindering consistent data quality and comparability across studies.
This real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In September 2021, a digital PCR system from Thermo Fisher Scientific was introduced. It is designed to deliver results that are highly accurate and consistent within 90 minutes
North America Real-time Polymerase Chain Reaction (qPCR) and Digital Polymerase Chain Reaction (dPCR) Devices Market Scope
The real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market is segmented on the basis of technology, product type, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
- Quantitative PCR
- Digital PCR
Product Type
- Reagents
- Consumables
- Instruments
- Software
Application
- Clinical Applications
- Research Applications
- Forensic Applications
- Others
End-User
- Hospitals
- Diagnostic Centres
- Ambulatory Centres
- Home Healthcare
- Clinics
- Community Healthcare
Real-time Polymerase Chain Reaction (qPCR) and Digital Polymerase Chain Reaction (dPCR) Devices Market Regional Analysis/Insights
The North America real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market is analyzed and market size insights and trends are provided by technology, product type, application, and end-user as referenced above.
The countries covered in this market report are the U.S., Canada, and Mexico.
The U.S. is expected to dominate the market and grow with a highest CAGR due to the increase in government initiatives to promote awareness, growing research activities in the region, availability of massive untapped markets, a large population pool, and the growing demand for quality healthcare in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices Market. The data is available for historic period 2015 to 2020.
Competitive Landscape and Real-time Polymerase Chain Reaction (qPCR) and digital Polymerase Chain Reaction (dPCR) Devices Market Share Analysis
The real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market.
Some of the major players operating in the real-time polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) devices market are:
- BioFire Diagnostics (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Cepheid (India)
- Analytik Jena AG (Germany)
- Meridian Bioscience, Inc. (U.S.)
- Promega Corporation (U.S.)
- BD (U.S.)
- Merck KGaA (Germany)
SKU-